ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 132 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,672,238 | -7.0% | 231,988 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $5,024,860 | -46.1% | 231,988 | -30.1% | 0.00% | -50.0% |
| Q2 2022 | $9,330,436 | +113.4% | 332,044 | +250.4% | 0.00% | +100.0% |
| Q1 2022 | $4,371,765 | -3.3% | 94,750 | +76.2% | 0.00% | 0.0% |
| Q4 2021 | $4,521,000 | +26.1% | 53,783 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $3,584,000 | +68.8% | 53,783 | +34.8% | 0.00% | – |
| Q2 2021 | $2,123,000 | +69.2% | 39,906 | +38.0% | 0.00% | – |
| Q1 2021 | $1,255,000 | +145.6% | 28,926 | +193.8% | 0.00% | – |
| Q4 2020 | $511,000 | – | 9,844 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |